一种以病毒为灵感的RNA模拟方法,用于有效的癌症免疫疗法
Iksoo Jang1, Kyuha Yum1, Sangwoo Han1
1Department of Chemical Engineering, University of Seoul, Republic of Korea.
Journal of materials chemistry. B
|January 21, 2025
概括
这项研究引入了富含尿素的纳米粒子 (UNPs),模仿病毒RNA激活癌细胞死亡途径. 这种新型的免疫疗法方法显示了减少瘤生长而没有不良影响的前景.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 目前的癌症疗法面临着诸如副作用和耐药性等挑战.
- 需要新的治疗策略,利用先天的免疫反应.
研究的目的:
- 为癌症治疗开发一种以病毒为灵感的RNA模拟方法.
- 研究富含尿素的纳米粒子 (UNP) 在向癌细胞中的有效性.
- 为了增强现有的RIG-I刺激器疗法.
主要方法:
- 通过滚动圆转录 (RCT) 合成富含尿素的纳米粒子 (UNPs).
- 设计的UNP模仿病毒RNA多U尾部序列.
- 研究了UNP与癌细胞中的RIG-I类受体 (RLR) 的接触.
主要成果:
- 在癌细胞中,UNPs激活了RLRs (MDA5,LGP2),诱导了促炎性细胞因子和亡.
- 在体内,UNPs显著减少了瘤生长,没有任何不良影响.
- 这种方法提高了现有的RIG-I刺激器的有效性.
结论:
- UNP代表了癌症免疫治疗的新有效策略.
- 这种方法利用先天的抗病毒机制来向癌细胞死亡.
- 联合国癌症疗法为传统癌症治疗提供了一个有前途的替代方案,其安全性和有效性得到了提高.
相关概念视频
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
siRNA - Small Interfering RNAs
16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


